- Report
- October 2024
- 195 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Alfadolone is a type of central nervous system (CNS) drug used to treat a variety of conditions, including anxiety, depression, and insomnia. It is a synthetic derivative of the naturally occurring hormone melatonin, and is believed to act on the brain's serotonin and melatonin receptors. Alfadolone is available in both oral and intravenous forms, and is often prescribed in combination with other CNS drugs.
Alfadolone is generally well-tolerated, with few side effects. Common side effects include headache, nausea, and dizziness. It is important to note that Alfadolone can interact with other medications, and should not be taken without consulting a doctor.
The Alfadolone market is a rapidly growing sector of the CNS drug market. It is increasingly being used to treat a variety of conditions, and is becoming more widely available.
Some companies in the Alfadolone market include Pfizer, Novartis, and Merck. Show Less Read more